Document is current
Any future updates will be listed below
-
Authors
Gholizadeh, Shervin
Exuzides, Alex
Sinnott, Jennifer
Palmer, Chella
Waltz, Michael
Rose, John W.
Jolley, Anna Marie
Behne, Jacinta M.
Behne, Megan K.
Blaschke, Terrence F.
Smith, Terry J.
Lewis, Katelyn E.
Cook, Lawrence J.
Yeaman, Michael R.
,
-
Funding
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
- License Information
-
More Information
Article History
Received: 1 April 2024
Accepted: 1 October 2024
First Online: 30 October 2024
Declarations
:
: The CIRCLES study was sponsored by The Guthy-Jackson Charitable Foundation. The present study was funded by Genentech, Inc. S. Gholizadeh is an employee of Genentech, Inc., and shareholder of F. Hoffmann-La Roche Ltd. A. Exuzides was an employee of Genentech, Inc., at the time of this study and manuscript preparation and is a shareholder of F. Hoffmann-La Roche Ltd. J. Sinnott has received research support from the Guthy-Jackson Charitable Foundation and the National Institutes of Health (NIH). C. Palmer and M. Waltz declare they have nothing to disclose. J. Rose has received research support from the National Multiple Sclerosis Society, Guthy-Jackson Charitable Foundation, NIH, Friends of MS, Biogen, and the US Department of Veterans Affairs. He has received intellectual property interests from a discovery or technology relating to health care. A. Jolley and J.M. Behne declare they have nothing to disclose. M.K. Behne has received personal compensation for serving as an independent contractor with the Guthy-Jackson Charitable Foundation. T.F. Blaschke has received personal compensation for serving as a consultant for Merck, the Guthy-Jackson Charitable Foundation, and the Bill and Melinda Gates Foundation. He has received personal compensation for serving as an officer or member of the board of directors for Durect. He has received personal compensation for serving as an editor, associate editor, or editorial advisory board member for Annual Reviews. He has received stock or ownership interest from Durect. He has received research support from the Bill and Melinda Gates Foundation. T.J. Smith has received personal compensation for serving as a consultant for Horizon and Immunovant. He has received personal compensation for serving on a scientific advisory or data safety monitoring board for Horizon. He has received intellectual property interests from a discovery or technology relating to health care. He is an advisor to the Guthy-Jackson Charitable Foundation. M.R. Yeaman has received personal compensation for serving on a scientific advisory committee for Genentech, Alexion, and Horizon. He has received research support from the NIH and US Department of Defense. He has received intellectual property interests from a discovery or technology relating to health care. He is an advisor to the Guthy-Jackson Charitable Foundation. K. Lewis declares she has nothing to disclose. L. Cook has received research support from the Centers for Disease Control and Prevention, Guthy-Jackson Charitable Foundation, Utah Highway Safety Office, and NIH.
: Enrollment was conducted in accordance with guidelines specified by the Office of Human Research Protections of the FDA. A standardized protocol, manual of operations, patient study file, and informed consent or assent documents were approved by institutional review boards or respective clinical study sites. All study protocols were approved by the University of Utah/Data Coordinating Center Institutional Review Board, and/or by respective CIRCLES study site Institutional Review Boards.
